PNW
66
3
VMC
57
-3
SWK
81
-3
GPC
37
-14
MAT
51
-3
DGX
39
-4
BF.B
43
-7
PG
51
3
MAR
60
7
HCP
64
-2
DHR
56
-4
MS
64
7
CL
58
2
NSC
62
-5
FMC
40
4
WAT
54
2
MPC
52
8
BAX
30
-3
RSG
59
2
PNC
57
-2
PNW
66
3
VMC
57
-3
SWK
81
-3
GPC
37
-14
MAT
51
-3
DGX
39
-4
BF.B
43
-7
PG
51
3
MAR
60
7
HCP
64
-2
DHR
56
-4
MS
64
7
CL
58
2
NSC
62
-5
FMC
40
4
WAT
54
2
MPC
52
8
BAX
30
-3
RSG
59
2
PNC
57
-2
Financhill
Back

Commercial Vehicle Group Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
48

CVGI
Commercial Vehicle Group

Last Price:
3.36
Seasonality Move:
1.76%
Sell
19

APLS
Apellis Pharmaceuticals

Last Price:
32.49
Seasonality Move:
18.8%
Sell
48
Commercial Vehicle Group (CVGI) is a Sell

Is Commercial Vehicle Group a Buy, Sell or Hold?

  • The current Commercial Vehicle Group [CVGI] share price is $3.36. The Score for CVGI is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CVGI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
19
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

CVGI Stock Price Chart

What is Commercial Vehicle Group's stock price today?

  • The Commercial Vehicle Group share price today is $3.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVGI is experiencing selling pressure, which indicates risk of future bearish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $32.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.

CVGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.17 Sell
Relative Strength Index (14 RSI): 43.76 Sell
Chaikin Money Flow: -139908 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.26 - 3.62) Sell
Bollinger Bands (100): (3.75 - 5.55) Sell

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.84 Sell
Relative Strength Index (14 RSI): 33.6 Sell
Chaikin Money Flow: -1084788 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.37 - 40.01) Sell
Bollinger Bands (100): (36.55 - 42.35) Sell

CVGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.31 Buy
20-day SMA: 3.39 Sell
50-day SMA: 4.05 Sell
200-day SMA: 5.58 Sell
8-day EMA: 3.33 Buy
20-day EMA: 3.42 Sell
50-day EMA: 3.89 Sell
200-day EMA: 5.37 Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.19 Sell
20-day SMA: 38.04 Sell
50-day SMA: 37.88 Sell
200-day SMA: 50 Sell
8-day EMA: 35.96 Sell
20-day EMA: 37.21 Sell
50-day EMA: 38.25 Sell
200-day EMA: 45.7 Sell

Commercial Vehicle Group Earnings Growth & CVGI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, an increase next quarter of $0.14 per share, a decrease this year of $0.66 per share, and an increase next year of $0.49 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.

Commercial Vehicle Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):